Key points are not available for this paper at this time.
This Review article is intended to highlight the analytical methods of Doxofylline in indivisual as well as combined pharmaceutical dosage form Doxofylline plays an important role in Asthma, COPD and various Respiratory diseases. Doxofylline is New generation long acting Oral methyl xanthine derivative. Doxofylline (7-(1.3 dioxolan-2ylmethy 1) 3.7 dihydro 13 dimethyl-1H purine 2. 6 Dione) is a newer generation xanthine with Broncho dilating and anti-inflammatory activities and for this reason it has been called Novofylline. Now these drugs are easily available in market in their indivisual form as well as combined Dosage form. Various analytical methods have been reported for the estimation of these drugs in their individuals as well as their combined Dosage form.
Ugale et al. (2024) studied this question.